Pancreatic Cancer Research

ResearcherSoochow UniversityNo recent work listed

Zhen Weng

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-5894-195X; OpenAlex author ID A5028082142. Sources: OpenAlex.

Their work

Papers
5 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2020: 2 papers · 2021: 1 paper · 2022: 2 papers

Papers 5

  1. Association of mucin family members with prognostic significance in pancreatic cancer patients: A meta-analysis. Last author DOI 10.1371/journal.pone.0269612↗
  2. The relationship between Helicobacter pylori and pancreatic cancer: a meta-analysis. Co-author DOI 10.21037/tcr-21-2803↗
  3. A 14-gene gemcitabine resistance gene signature is significantly associated with the prognosis of pancreatic cancer patients. Co-author DOI 10.1038/s41598-021-85680-x↗
  4. Albendazole suppresses cell proliferation and migration and induces apoptosis in human pancreatic cancer cells. First author DOI 10.1097/cad.0000000000000914↗
  5. Albendazole regulates radiosensitivity of human pancreatic cancer cells by inhibiting HIF-1α and basic fibroblast growth factor Co-author DOI 10.21203/rs.2.20141/v2↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chunfang Xu · 4 shared papers, 2020–2022 · strength 0.72
  2. Wei Xu · 2 shared papers, 2022 · strength 0.37
  3. Minyue Yin · 2 shared papers, 2022 · strength 0.37
  4. Yang He · 2 shared papers, 2020–2021 · strength 0.29
  5. Xing Chang Wei · 2 shared papers, 2020–2021 · strength 0.29
  6. Haifeng Chen · 1 shared paper, 2020 · strength 0.19
  7. Haifeng Chen · 1 shared paper, 2020 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.